Wednesday, February 8, 2023
Mitochondrial Health

Cancer As A Metabolic Disease: Implications For Novel Therapeutics – Thomas N. Seyfried, PhD

New 2022 – Cancer As A Metabolic Disease: Implications For Novel Therapeutics – Thomas N. Seyfried, PhD

Dr. Thomas Seyfried,
• Contact: [email protected]
• Book – Cancer as a Metabolic Disease

#ThomasSeyfried #Cancer #MetabolicDisease

00:02:07 Mitochondrial Respiratory Damage Is The Origin Of Cancer
00:10:28 Evidence That Challenges The Somatic Mutation Theory Of Cancer
00:26:32 If We Target Glucose And Glutamine We Can Manage The Majority Of Cancers
00:40:33 A Novel Therapeutic Strategy For The Metabolic Management Of Cancer
00:51:20 Stage 4 Cancers Should Not Be Considered Terminal If Treated With KMT
01:19:59 Is It Safe For People With Cancer To Eat Fruit And Beans?
01:30:00 Is There A Greater Risk Of Brain Cancer From Cell Phone Use For Younger People?

Dr. Thomas Seyfried, is a professor and author publishing a groundbreaking book; Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer.
This book addresses controversies related to the origins of cancer and provides solutions to cancer management and prevention. It expands upon Otto Warburg’s well-known theory that all cancer is a disease of energy metabolism. However, Warburg did not link his theory to the “hallmarks of cancer” and thus his theory was discredited.
This book aims to provide evidence, through case studies, that cancer is primarily a metabolic disease requiring metabolic solutions for its management and prevention. Support for this position is derived from critical assessment of current cancer theories. Brain cancer case studies are presented as a proof of principle for metabolic solutions to disease management, but similarities are drawn to other types of cancer, including breast and colon, due to the same cellular mutations that they demonstrate.
The book also provides extensive information showing that cancer can be best defined as a mitochondrial metabolic disease rather than as a genetic disease. This new concept has implications for the development of new non-toxic cancer therapies including the ketogenic diet. Experts in the cancer research field have praised this comprehensive study as one of science’s hottest topics.
Dr. Thomas Seyfried received his Ph.D. in Genetics and Biochemistry from the University of Illinois, Urbana. He did his undergraduate work at the University of New England, where he recently received the distinguished Alumni Achievement Award. He has a Master’s degree in Genetics from Illinois State University.
Thomas Seyfried served with distinction in the United States Army’s during the Vietnam War and received numerous medals and commendations. He was a Postdoctoral Fellow in the Department of Neurology at the Yale University School of Medicine and then served on the faculty as an Assistant Professor in Neurology.
Other awards and honors have come from such diverse organizations as the American Oil Chemists Society, the National Institutes of Health, The American Society for Neurochemistry, and the Ketogenic Diet Special Interest Group of the American Epilepsy Society.
Dr. Seyfried previously served as Chair, Scientific Advisory Committee for the National Tay-Sachs and Allied Diseases Association and presently serves on several editorial boards, including those for Nutrition & Metabolism, Neurochemical Research, the Journal of Lipid Research, and ASN Neuro, where he is a Senior Editor.
Dr. Seyfried has over 150 peer-reviewed publications and is the author of the book “Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer (Wiley Press).”
To Contact Dr Thomas N. Seyfried, Ph.D. email: [email protected]


• Social Media Channels
Instagram :

• Check out our Podcasts

Visit us on Apple Podcast and Itunes search: The Real Truth About Health Free 17 Day Live Online Conference Podcast



Similar Posts

Leave a Reply

Your email address will not be published.